This study was designed to determine the expression of cyclin D1 protein and Ki-67 in in?situ, metastatic and non?metastatic thin melanomas (?1 mm Breslow thickness).
Scientific Publications
Prostate-specific membrane antigen expression in melanoma metastases
This study is done to assess the performance of prostate?specific membrane antigen (PSMA) immunohistochemistry on resected melanoma metastases, to ultimately determine its use as a diagnostic imaging biomarker for melanoma.
Melanoma risk in patients treated with biologic therapy for common inflammatory diseases: A systematic review and meta-analysis
Researchers searched Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials (CENTRAL) for articles published from January 1, 1995 to February 7, 2019 to assess if biologic treatment of inflammatory bowel disease, rheumatoid arthritis, or psoriasis is correlated with an increased risk of melanoma vs conventional systemic therapy.
Dermatoscopic features of thin (less than or equal to 2mm Breslow thickness) vs thick (> 2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma vs nodular non-melanoma tumors: A multicentric collaborative study by the International Dermoscopy Society
Dermatoscopic images of NM and other nodular tumors from 19 skin cancer centers worldwide have been collected and analyzed.